A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection

Trial Profile

A Phase 1 Study of Paclitaxel and Carboplatin in Solid Tumors (With Focus on Upper Aerodigestive Cancers) in Persons With HIV Infection

Discontinued
Phase of Trial: Phase I

Latest Information Update: 29 Aug 2017

At a glance

  • Drugs Vorinostat (Primary) ; Carboplatin; Paclitaxel
  • Indications Anal cancer; Breast cancer; Gastric cancer; Head and neck cancer; Laryngeal cancer; Nasopharyngeal cancer; Non-small cell lung cancer; Oesophageal cancer; Oropharyngeal cancer; Ovarian cancer; Salivary gland cancer; Solid tumours; Squamous cell cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Aug 2017 Status changed from active, no longer recruiting to discontinued due to inadequate accrual rate.
    • 10 Jun 2017 Biomarkers information updated
    • 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top